Gut microbiota disturbance during antibiotic therapy: a multi-omic approach
about
Microbiota-based treatments in alcoholic liver diseaseThe effects of antibiotics on the microbiome throughout development and alternative approaches for therapeutic modulationModulating Composition and Metabolic Activity of the Gut Microbiota in IBD PatientsThe New Era of Treatment for Obesity and Metabolic Disorders: Evidence and Expectations for Gut Microbiome TransplantationAntibiotics and the Human Gut Microbiome: Dysbioses and Accumulation of ResistancesThe Gastrointestinal Microbiome: Alcohol Effects on the Composition of Intestinal MicrobiotaInfluence of environmental factors on the onset and course of inflammatory bowel diseaseThe Intestinal Microbiota in Inflammatory Bowel DiseaseExploring the avian gut microbiota: current trends and future directionsThe bacteriome-mycobiome interaction and antifungal host defenseThe dynamic microbiomeFecal Microbiota-based Therapeutics for Recurrent Clostridium difficile Infection, Ulcerative Colitis and ObesityFiber and prebiotic supplementation in enteral nutrition: A systematic review and meta-analysisFaecal Metaproteomic Analysis Reveals a Personalized and Stable Functional Microbiome and Limited Effects of a Probiotic Intervention in AdultsActive and Secretory IgA-Coated Bacterial Fractions Elucidate Dysbiosis in Clostridium difficile InfectionEffect of postnatal low-dose exposure to environmental chemicals on the gut microbiome in a rodent modelApproaches to studying and manipulating the enteric microbiome to improve autism symptomsNavigating through metaproteomics data: a logbook of database searching.Helminth colonization is associated with increased diversity of the gut microbiota.Introduction to the human gut microbiotaTeleost microbiomes: the state of the art in their characterization, manipulation and importance in aquaculture and fisheriesGut microbiota disturbance during antibiotic therapy: a multi-omic approachCarbadox has both temporary and lasting effects on the swine gut microbiota.Metaproteomic analysis of human gut microbiota: where are we heading?Exercise induction of gut microbiota modifications in obese, non-obese and hypertensive ratsInfluence of a probiotic mixture on antibiotic induced microbiota disturbances.Association of a probiotic to a Helicobacter pylori eradication regimen does not increase efficacy or decreases the adverse effects of the treatment: a prospective, randomized, double-blind, placebo-controlled study.Microbiota and the gut-liver axis: bacterial translocation, inflammation and infection in cirrhosis.Insights from quantitative metaproteomics and protein-stable isotope probing into microbial ecology.Functional consequences of microbial shifts in the human gastrointestinal tract linked to antibiotic treatment and obesity.High-fat diet alters gut microbiota physiology in mice.Comparative genome analysis of Megasphaera sp. reveals niche specialization and its potential role in the human gutDifferential effects of antibiotic therapy on the structure and function of human gut microbiota.Ranking the impact of human health disorders on gut metabolism: systemic lupus erythematosus and obesity as study cases.Cephalosporinases associated with outer membrane vesicles released by Bacteroides spp. protect gut pathogens and commensals against β-lactam antibioticsChanges in the equine fecal microbiota associated with the use of systemic antimicrobial drugsAltered profile of human gut microbiome is associated with cirrhosis and its complications.Microbiome changes in healthy volunteers treated with GSK1322322, a novel antibiotic targeting bacterial peptide deformylase.Gut Health in the era of the human gut microbiota: from metaphor to biovalue.Diet effects in gut microbiome and obesity.
P2860
Q26740192-06493714-9FA2-4DBB-B8DB-5F527ACD247EQ26748672-7B320608-DC70-4950-845A-4A2581B835B3Q26750985-F475FEF2-51C5-4817-BD03-0AEDEBE3B461Q26765740-717893A6-6EAD-4761-8584-D5DE854FDD12Q26770392-0E74EF1D-2C7E-4EB0-A142-348B7D7CEC87Q26773227-3FCD8C21-47A4-475A-B340-D286775D3015Q26774548-F8D8CD91-D3FC-4AC4-924B-D873672C6F81Q26795705-A9056AF9-6C93-4F2F-AD57-9A38826EC505Q26801978-6C1A69CE-70AC-425A-AA50-2531BE4C7D31Q26851477-34B6F404-F3C1-4352-8D1C-9F3254636EC3Q27027596-F7847A25-529D-464F-AC18-07FEA060585AQ28070349-6315D37A-F07B-4F17-A68A-A5C2402A40FDQ28084743-FDCC6E6F-9CFE-4584-A3FA-95ACAECBEDC9Q28551279-B810B0B0-F7CC-4220-A96F-0413465591B7Q28829566-7D8F6D22-DA99-4BDC-A6DF-44F7D009A1F8Q28830434-0534B8FA-A530-41AF-B5BD-8135692972B0Q30410992-3319F109-34FE-42A4-AC31-A2D42C51A048Q30911195-B3F09B90-7248-4B79-94E8-D4A81EA08CCDQ33650329-644BC169-249E-4B38-B75D-79B451C879CEQ33693158-BBC87E44-C713-4451-BB3C-AEFB7C6CE9E4Q33693827-08D31D28-A474-49D2-BF90-EB92852FD985Q33728322-728B457B-4729-4714-84C4-BD1976A1F77AQ33731279-1E15BFDF-7E67-46E0-890A-59F8446039AAQ33791814-EA67881E-BE08-4D10-B063-3162AC46A0E2Q33848765-E6CA9F52-8AEC-44AF-ADE0-E6D6F23C3BB0Q34137444-568E81A4-89BB-4456-B9E2-0D56C352AE7CQ34636521-E332F60D-22E6-4761-B807-0D51D421CD14Q34647371-00F5A49E-39E3-4A5A-972F-746524C29BF3Q34724702-CB897B3D-AE17-49F0-8219-BDDBAA2DEB79Q34778080-1C94D7CC-C220-4367-916B-9AE90664A5D0Q34986213-30931CA9-529A-4B5F-8909-302D85B9E7B4Q35048371-3F79B796-DCBC-475F-8437-7387B0B08D97Q35055063-04D02FF9-D3B4-4CD9-B260-C0F86725341CQ35056044-AF36B8B1-3FA3-4558-B4A5-D64740444BF2Q35056882-0C2AF964-6269-4E59-8209-5984CF4E202BQ35068521-33C845B3-21BE-410A-85BC-19F8FA78F415Q35077209-39B7620A-3156-4CCB-A07A-E174E7744EAAQ35105814-38F95E6A-7DAD-4D4F-A97C-42870DB32407Q35115051-95CB6313-E852-49EF-A4FE-AD9B4AA6DB43Q35118425-B55BFA10-0EDB-457B-8666-BA776D650DFE
P2860
Gut microbiota disturbance during antibiotic therapy: a multi-omic approach
description
im November 2013 veröffentlichter wissenschaftlicher Artikel
@de
wetenschappelijk artikel
@nl
наукова стаття, опублікована в листопаді 2013
@uk
name
Gut microbiota disturbance during antibiotic therapy: a multi-omic approach
@en
Gut microbiota disturbance during antibiotic therapy: a multi-omic approach
@nl
type
label
Gut microbiota disturbance during antibiotic therapy: a multi-omic approach
@en
Gut microbiota disturbance during antibiotic therapy: a multi-omic approach
@nl
prefLabel
Gut microbiota disturbance during antibiotic therapy: a multi-omic approach
@en
Gut microbiota disturbance during antibiotic therapy: a multi-omic approach
@nl
P2093
P2860
P50
P1433
P1476
Gut microbiota disturbance during antibiotic therapy: a multi-omic approach
@en
P2093
Alejandro Artacho
Anette Friedrichs
Carolin Däumer
David Rojo
Femke-Anouska Heinsen
Henrik Knecht
Kathleen Eismann
Martin von Bergen
María José Gosalbes
Stephan J Ott
P2860
P304
P356
10.1136/GUTJNL-2012-303184
P407
P577
2013-11-01T00:00:00Z